Literature DB >> 15220383

The protective effect of superoxide dismutase mimetic M40401 on balloon injury-related neointima formation: role of the lectin-like oxidized low-density lipoprotein receptor-1.

Carolina Muscoli1, Iolanda Sacco, Wanessa Alecce, Ernesto Palma, Robert Nisticò, Nicola Costa, Fabrizio Clementi, Domenicantonio Rotiroti, Francesco Romeo, Daniela Salvemini, Jawahar L Mehta, Vincenzo Mollace.   

Abstract

Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), the principal receptor for oxidized low-density lipoprotein (ox-LDL) in vascular endothelial cells (ECs), has recently been suggested to exert a pivotal role in atherogenesis, possibly by mediating ox-LDL-evoked endothelial dysfunction. On the other hand, LOX-1 expression seems to strongly correlate with the oxidative stress occurring in the vascular wall of experimentally injured blood vessels. Here, we investigated LOX-1 expression and superoxide generation during neointima formation in a balloon injury rat carotid artery model. To test this, we used M40401 [a manganese(II) complex with a bis(cyclo-hexylpyridine-substituted) macrocyclic ligand], a synthetic superoxide dismutase mimetic that is a selective scavenger of superoxide. The injury was performed inserting the balloon catheter through the rat common carotid artery and after 14 days a histopathological analysis revealed a significant restenosis with smooth muscle cell proliferation and neointima formation that was associated with an enhanced expression of LOX-1, nitrotyrosine (the footprint of peroxynitrite) staining, and lipid peroxidation as assessed by malondialdehyde (MDA) formation. Pretreatment of rats with M40401 (0.5-10 mg/kg i.p. daily) reduced neointima formation, MDA accumulation, nitrotyrosine staining, and LOX-1 expression. Here, we show that removal of superoxide formation occurring in injured arteries reduces both neointima formation and LOX-1 expression and that this may represent a novel therapeutical approach in the treatment of vascular disorders in which proliferation of vascular smooth muscle cells and ox-LDL-related endothelial cell dysfunction occur.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15220383     DOI: 10.1124/jpet.104.068205

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  13 in total

Review 1.  Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury.

Authors:  Christopher A Papaharalambus; Kathy K Griendling
Journal:  Trends Cardiovasc Med       Date:  2007-02       Impact factor: 6.677

Review 2.  Antioxidant pharmacological therapies for COPD.

Authors:  Irfan Rahman; William MacNee
Journal:  Curr Opin Pharmacol       Date:  2012-02-18       Impact factor: 5.547

Review 3.  Pharmacological antioxidant strategies as therapeutic interventions for COPD.

Authors:  Irfan Rahman
Journal:  Biochim Biophys Acta       Date:  2011-11-09

4.  Nitric oxide inhibits neointimal hyperplasia following vascular injury via differential, cell-specific modulation of SOD-1 in the arterial wall.

Authors:  Edward S M Bahnson; Nathaniel Koo; Nadiezhda Cantu-Medellin; Aaron Y Tsui; George E Havelka; Janet M Vercammen; Qun Jiang; Eric E Kelley; Melina R Kibbe
Journal:  Nitric Oxide       Date:  2014-11-07       Impact factor: 4.427

Review 5.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

Review 6.  Strategies to decrease ongoing oxidant burden in chronic obstructive pulmonary disease.

Authors:  Irfan Rahman; Vuokko L Kinnula
Journal:  Expert Rev Clin Pharmacol       Date:  2012-05       Impact factor: 5.045

Review 7.  Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors.

Authors:  Pál Pacher; Csaba Szabó
Journal:  Cardiovasc Drug Rev       Date:  2007

Review 8.  Antioxidant therapeutic advances in COPD.

Authors:  Irfan Rahman
Journal:  Ther Adv Respir Dis       Date:  2008-12       Impact factor: 4.031

Review 9.  Peroxynitrite and opiate antinociceptive tolerance: a painful reality.

Authors:  Daniela Salvemini
Journal:  Arch Biochem Biophys       Date:  2008-11-11       Impact factor: 4.013

10.  Sex-based differential regulation of oxidative stress in the vasculature by nitric oxide.

Authors:  Rommel C Morales; Edward S M Bahnson; George E Havelka; Nadiezhda Cantu-Medellin; Eric E Kelley; Melina R Kibbe
Journal:  Redox Biol       Date:  2015-01-13       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.